Hugo ids | Gene description | Fra. site | Involvement in cancer | |
---|---|---|---|---|
 |  |  | Notes | References |
GLMN | glomulin, FKBP associated protein | FRA1D | familial glomangioma | GCd |
CLCA3 | chloride channel, calcium activated | FRA1D | strictly linked to CLCA2, tumor suppressor gene for breast cancer | Oncogene 2004 (19): 1471-80 |
EVI-5 | EVI-5 homolog | FRA1D | Â | Cell 2006 Jan 27; 124(2): 367-80 |
TNFSF4 | TNF(ligand) superfamily, member 4 | FRA1G | leukemia T-cell, neoplasms | AGCOH, GCd |
TNFSF18 | TNF(ligand) superfamily, member 18 | FRA1G | neoplasms | AGCOH |
TNR | tenascin R | FRA1G | neoplasms | AGCOH |
ANGPTL1 | Angiopoietin-related protein 1 precursor | FRA1G | neoplasms | Cancer Cell 2004 Nov; 6(5):507-16 |
ITGAV | CD51 antigen | FRA2H | neoplasm metastasis, colon, breast and pancreatic carcinoma | Cancer Metastasis Rev 2003 Mar;22(1):103-15 |
FAM3D | family with sequence similarity 3, member D | FRA3B | located 900 kb, with no intervening genes, distal from FHIT gene | Â |
THPO | thrombopoietin | FRA3C | myeloproliferative disorders | AGCOH, GCd |
ADIPOQ | adiponectin, C1Q and collagen domain containing | FRA3C | myeloblastic leukemia | Br J Cancer 2006 Jan 16; 94(1):156-60 |
AHSG | alpha-2-HS-glycoprotein | FRA3C | liver carcinoma | GCd |
BCL6 | B-cell CLL/lymphoma 6 | FRA3C | lymphoma b-cell, lymphoma non-hodgkins, burkitt lymphoma | Oncogene 2006 Jul 3 |
PLG | plasminogen precursor | FRA6E | neoplasm metastasis, neoplasms vascular tissue | J Cell Biochem 2005 Oct; 96(2):242-61 |
HOXA5 | homeo box A5 | 7p15.2 | breast carcinoma | J Biol Chem 2000 Aug ; 275(34):26551-5 |
HOXA7,9 | homeo box A7, A9 | 7p15.2 | myeloid leukemia | Leuk Res 2000 Oct; 24(10): 849-55 |
EPO | erythropoietin | FRA7F | myelodyplastic syndromes | AGCOH, GCd |
AZGP1 | alpha-2-glycoprotein 1, zinc | FRA7F | cancer of breast, prostate (GCd) | AGCOH |
PBEF1 | pre-B-cell colony enhancing factor 1 | FRA7F | myeloid leukemia | Leukemia 2005 Jun; 19(6): 998-1004 |
CAV-1,-2 | caveolin 1, caveolin 2 | FRA7G | carcinoma of colon, adenocarcinoma, ovarian epithelial carcinoma | Genomics 2003 Feb; 81(2):105-7 |
MET | HGF receptor | FRA7G | gastric carcinoma, neoplasm metastasis, carcinoma renal cell | Oncogene 2006 Jan 19; 25(3):409-18 |
INFB1 | interferon beta 1 | FRA9C | neoplasms, melanoma | AGCOH, GCd |
IFNE1 | interferon epsilon 1 | FRA9C | located 350 kb distal from MTAP, CDKN2A and CGKN2B tumor genes | Â |
IFNA1 | interpheron alpha 1 | FRA9C | leukemia | AGCOH, GCd |
IFNA2 | interpheron alpha 2 | FRA9C | myeloid leukemia, renal cell cancer | GCd, TGD |
SMPD3 | sphingomyelin phosphodiesterase 3 | FRA16C | strictly linked to CDH3 (P-cadherin tumour gene) | Â |
CKLF | chemokine-like factor | FRA16C | strictly linked to CDH5 (P-cadherin tumour gene) | Â |
CES2 | Carboxylesterase 2 precursor | FRA16C | malignant neoplasms, carcinoma of colon | Neoplasia 2005 Apr;7(4): 407-16 |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | FRA16C | carcinoma of colon, malignant neoplasm of lung, cancer of bladder | Clin Cancer Res 2005 Dec; 11(24):8866-71 |
LIF | leukemia inhibitory factor | FRA22B | leukemia, myeloma, neuroepitelioma, stricltly linked to HORMAD2 | AGCOH, TGD |
OSM | oncostatin M | FRA22B | leukemia, myeloma, kaposi sarcoma, melanoma, plasmacitoma | AGCOH, TGD |
TCN2 | transcobalamin II, macrocytic anemia | FRA22B | colon adenocarcinoma | GCd |
SEC14L2 | SEC14-like 2 | FRA22B | neoplasms | Cancer Res 2005 Nov 1; 65(21):9807-16 |